Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chin Hur, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA212086 (HUR, CHIN) Aug 1, 2017 - Jul 31, 2022
    NIH/NCI
    Optimizing the Treatment of Pancreatic Adenocarcinoma
    Role: Principal Investigator
  2. U01CA199336 (HUR, CHIN) Sep 1, 2015 - Aug 31, 2020
    NIH/NCI
    Controlling Esophageal Cancer: A Collaborative Modeling Approach
    Role: Principal Investigator
  3. U01CA182940 (LUEBECK, GEORG E.) Sep 17, 2013 - Aug 31, 2018
    NIH/NCI
    Esophageal Cancer from Cells to Population: A Multiscale Approach
    Role: Principal Investigator
  4. U01CA152926 (HUR, CHIN) Sep 1, 2010 - Aug 31, 2015
    NIH/NCI
    Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project
    Role: Principal Investigator
  5. R01CA140574 (HUR, CHIN) Feb 8, 2010 - Mar 31, 2019
    NIH/NCI
    Improving Esophageal Adenocarcinoma Prevention, Screening and Treatment
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Stanford FC, Lee M, Hur C. Race, Ethnicity, Sex, and Obesity: Is It Time to Personalize the Scale? Mayo Clin Proc. 2019 Feb; 94(2):362-363. PMID: 30711132.
    Citations:    
  2. Weaver DT, Lietz AP, Mercaldo SF, Peters MLB, Hur C, Kong CY, Wolpin BM, Megibow AJ, Berland LL, Knudsen AB, Pandharipande PV. Testing for Verification Bias in Reported Malignancy Risks for Side-Branch Intraductal Papillary Mucinous Neoplasms: A Simulation Modeling Approach. AJR Am J Roentgenol. 2019 Jan 08; 1-6. PMID: 30620679.
    Citations:    Fields:    
  3. Sheehan DF, Criss SD, Chen Y, Eckel A, Palazzo L, Tramontano AC, Hur C, Cipriano LE, Kong CY. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare. Cancer Med. 2019 Jan; 8(1):94-103. PMID: 30575329.
    Citations:    Fields:    
  4. Choi JG, Nipp RD, Tramontano A, Ali A, Zhan T, Pandharipande P, Dowling EC, Ferrone CR, Hong TS, Schrag D, Fernandez-Del Castillo C, Ryan DP, Kong CY, Hur C. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2018 Dec 17. PMID: 30559125.
    Citations:    Fields:    
  5. Nipp RD, Tramontano AC, Kong CY, Hur C. Patterns and predictors of end-of-life care in older patients with pancreatic cancer. Cancer Med. 2018 Dec; 7(12):6401-6410. PMID: 30426697.
    Citations:    Fields:    
  6. Chu JN, Choi J, Ostvar S, Torchia JA, Reynolds KL, Tramontano A, Gainor JF, Chung DC, Clark JW, Hur C. Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Cancer. 2019 Jan 15; 125(2):278-289. PMID: 30343509.
    Citations:    Fields:    
  7. Ali A, Zachrison KS, Eschenfeldt PC, Schwamm LH, Hur C. Optimization of Prehospital Triage of Patients With Suspected Ischemic Stroke. Stroke. 2018 Oct; 49(10):2532-2535. PMID: 30355100.
    Citations:    Fields:    
  8. Lin EC, Holub J, Lieberman D, Hur C. Low Prevalence of Suspected Barrett's Esophagus in Patients with Gastroesophageal Reflux Disease Without Alarm Symptoms. Clin Gastroenterol Hepatol. 2018 Sep 07. PMID: 30196157.
    Citations:    Fields:    
  9. Bethea ED, Samur S, Kanwal F, Ayer T, Hur C, Roberts MS, Terrault N, Chung RT, Chhatwal J. Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy. Clin Gastroenterol Hepatol. 2018 Aug 21. PMID: 30138735.
    Citations:    Fields:    
  10. Tramontano AC, Nipp R, Mercaldo ND, Kong CY, Schrag D, Hur C. Survival Disparities by Race and Ethnicity in Early Esophageal Cancer. Dig Dis Sci. 2018 Nov; 63(11):2880-2888. PMID: 30109578.
    Citations:    Fields:    
  11. Peters MLB, Eckel A, Mueller PP, Tramontano AC, Weaver DT, Lietz A, Hur C, Kong CY, Pandharipande PV. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model. Pancreatology. 2018 Dec; 18(8):928-934. PMID: 30143405.
    Citations:    Fields:    
  12. Tramontano AC, Nipp R, Kong CY, Yerramilli D, Gainor JF, Hur C. Hospice use and end-of-life care among older patients with esophageal cancer. Health Sci Rep. 2018 Sep; 1(9):e76. PMID: 30623099.
    Citations:    
  13. Thein HH, Jembere N, Thavorn K, Chan KKW, Coyte PC, de Oliveira C, Hur C, Earle CC. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study. BMC Cancer. 2018 Jun 27; 18(1):694. PMID: 29945563.
    Citations:    Fields:    Translation:Humans
  14. Eschenfeldt PC, Kartoun U, Heberle CR, Kong CY, Nishioka NS, Ng K, Kamarthi S, Hur C. Analysis of factors associated with extended recovery time after colonoscopy. PLoS One. 2018; 13(6):e0199246. PMID: 29927978.
    Citations:    Fields:    
  15. Hur C, Zhan T, Thrift AP, Vaughan TL, Feuer EJ. Lorenz Curves and Gini Coefficient Analyses Indicate Inefficiencies in Esophageal Adenocarcinoma Screening. Clin Gastroenterol Hepatol. 2019 Feb; 17(3):560-562.e2. PMID: 29753084.
    Citations: 1     Fields:    
  16. Zhan T, Ali A, Choi JG, Lee M, Leung J, Dellon ES, Garber JJ, Hur C. Model to Determine the Optimal Dietary Elimination Strategy for Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2018 Nov; 16(11):1730-1737.e2. PMID: 29730438.
    Citations:    Fields:    
  17. Chhatwal J, Samur S, Bethea ED, Ayer T, Kanwal F, Hur C, Roberts MS, Terrault N, Chung RT. Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study. Hepatology. 2018 06; 67(6):2085-2095. PMID: 29222916.
    Citations:    Fields:    Translation:Humans
  18. Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal J. Reply. Hepatology. 2018 04; 67(4):1641-1642. PMID: 29315738.
    Citations:    Fields:    
  19. Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal J. Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology. 2018 03; 67(3):837-846. PMID: 29059461.
    Citations: 1     Fields:    Translation:Humans
  20. Nipp R, Tramontano AC, Kong CY, Pandharipande P, Dowling EC, Schrag D, Hur C. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018 02; 7(2):525-535. PMID: 29322643.
    Citations: 2     Fields:    
  21. Kubiliun M, Patel SJ, Hur C, Dienstag JL, Luther J. Early liver transplantation for alcoholic hepatitis: Ready for primetime? J Hepatol. 2018 Mar; 68(3):380-382. PMID: 29175244.
    Citations: 1     Fields:    
  22. Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol. 2018 Mar; 16(3):392-400.e7. PMID: 29079222.
    Citations:    Fields:    
  23. Lockwood R, Ozanne E, Hur C, Yachimski P. Patient decision-making and clinical outcomes following endoscopic therapy or esophagectomy for Barrett's neoplasia. Endosc Int Open. 2017 Nov; 5(11):E1128-E1135. PMID: 29124122.
    Citations:    
  24. Kabrhel C, Ali A, Choi JG, Hur C. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis. Acad Emerg Med. 2017 10; 24(10):1235-1243. PMID: 28650086.
    Citations:    Fields:    Translation:Humans
  25. Klebanoff MJ, Chhatwal J, Hur C. Acceptance of Surgical Treatment for Adolescent Obesity-Reply. JAMA Surg. 2017 Aug 01; 152(8):802. PMID: 28384656.
    Citations:    Fields:    
  26. Samur S, Kues B, Ayer T, Roberts MS, Kanwal F, Hur C, Donnell DMS, Chung RT, Chhatwal J. Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):115-122.e10. PMID: 28634131.
    Citations: 2     Fields:    Translation:Humans
  27. Lubitz C, Ali A, Zhan T, Heberle C, White C, Ito Y, Miyauchi A, Gazelle GS, Kong CY, Hur C. The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population. PLoS One. 2017; 12(5):e0177068. PMID: 28481909.
    Citations:    Fields:    Translation:Humans
  28. Tramontano AC, Sheehan DF, Yeh JM, Kong CY, Dowling EC, Rubenstein JH, Abrams JA, Inadomi JM, Schrag D, Hur C. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol. 2017 Aug; 112(8):1256-1264. PMID: 28374815.
    Citations: 5     Fields:    Translation:Humans
  29. Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano AC, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hur C. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1397-1404.e7. PMID: 28238953.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  30. Klebanoff MJ, Corey KE, Chhatwal J, Kaplan LM, Chung RT, Hur C. Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. Hepatology. 2017 04; 65(4):1156-1164. PMID: 27880977.
    Citations: 3     Fields:    Translation:Humans
  31. Yeh JM, Tramontano AC, Hur C, Schrag D. Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study. Gastric Cancer. 2017 Sep; 20(5):811-824. PMID: 28205057.
    Citations:    Fields:    Translation:Humans
  32. Klebanoff MJ, Chhatwal J, Nudel JD, Corey KE, Kaplan LM, Hur C. Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity. JAMA Surg. 2017 02 01; 152(2):136-141. PMID: 27784062.
    Citations: 3     Fields:    Translation:Humans
  33. Samur S, Klebanoff M, Banken R, Pratt DS, Chapman R, Ollendorf DA, Loos AM, Corey K, Hur C, Chhatwal J. Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Hepatology. 2017 03; 65(3):920-928. PMID: 27906472.
    Citations: 7     Fields:    Translation:Humans
  34. Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1471-1474. PMID: 28089850.
    Citations: 1     Fields:    
  35. Chhatwal J, Samur S, Kues B, Ayer T, Roberts MS, Kanwal F, Hur C, Donnell DM, Chung RT. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list. Hepatology. 2017 03; 65(3):777-788. PMID: 27906468.
    Citations: 4     Fields:    Translation:Humans
  36. Yachimski P, Hur C. Endoscopic therapy versus surgery for T1 colon cancer: defining model clinical practice. Gastrointest Endosc. 2016 12; 84(6):995-996. PMID: 27855802.
    Citations:    Fields:    Translation:Humans
  37. Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving. Clin Gastroenterol Hepatol. 2017 Jun; 15(6):827-837.e8. PMID: 27650326.
    Citations: 6     Fields:    Translation:HumansCells
  38. Hur C, Tramontano AC, Dowling EC, Brooks GA, Jeon A, Brugge WR, Gazelle GS, Kong CY, Pandharipande PV. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening. Pancreas. 2016 08; 45(7):1062-6. PMID: 26692444; PMCID: PMC4912943.
    Citations: 1     Fields:    Translation:Humans
  39. Nguyen L, Hur C. Proton Pump Inhibitors and Dementia Incidence. JAMA Neurol. 2016 08 01; 73(8):1027-8. PMID: 27322752.
    Citations:    Fields:    Translation:Humans
  40. Chhatwal J, Wang X, Ayer T, Kabiri M, Chung RT, Hur C, Donohue JM, Roberts MS, Kanwal F. Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals. Hepatology. 2016 11; 64(5):1442-1450. PMID: 27015107.
    Citations: 21     Fields:    Translation:Humans
  41. Corey KE, Klebanoff MJ, Tramontano AC, Chung RT, Hur C. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Dig Dis Sci. 2016 07; 61(7):2108-17. PMID: 26825843.
    Citations: 5     Fields:    Translation:Humans
  42. Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted Screening of Individuals at High Risk for Pancreatic Cancer: Results of a Simulation Model. Radiology. 2016 Jan; 278(1):306. PMID: 26691000.
    Citations:    Fields:    
  43. Pandharipande PV, Jeon A, Heberle CR, Dowling EC, Kong CY, Chung DC, Brugge WR, Hur C. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model. EBioMedicine. 2015 Dec; 2(12):1980-6. PMID: 26844277.
    Citations: 3     Fields:    Translation:Humans
  44. Oh S, Kim H, Hur CY. The Usefulness of Mini-Laparoscopic Cystectomy for Small Endometrioma in Adolescent Women. J Minim Invasive Gynecol. 2015 Nov-Dec; 22(6S):S195. PMID: 27679016.
    Citations:    Fields:    
  45. King LP, Ricciotti H, Klebanoff MJ, Hur C, Hur HC. Fibroid Morcellation: A Shared Clinical Decision Tool for Mode of Hysterectomy. J Minim Invasive Gynecol. 2015 Nov-Dec; 22(6S):S97-S98. PMID: 27679390.
    Citations:    Fields:    
  46. Hur HC, King LP, Klebanoff MJ, Hur C, Ricciotti HA. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2015 Dec; 195:122-7. PMID: 26520875.
    Citations: 2     Fields:    Translation:Humans
  47. Simon RE, Pearson SD, Hur C, Chung RT. Tackling the hepatitis C cost problem: A test case for tomorrow's cures. Hepatology. 2015 Nov; 62(5):1334-6. PMID: 26359645.
    Citations: 4     Fields:    Translation:Humans
  48. Protano MA, Xu H, Wang G, Polydorides AD, Dawsey SM, Cui J, Xue L, Zhang F, Quang T, Pierce MC, Shin D, Schwarz RA, Bhutani MS, Lee M, Parikh N, Hur C, Xu W, Moshier E, Godbold J, Mitcham J, Hudson C, Richards-Kortum RR, Anandasabapathy S. Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial. Gastroenterology. 2015 Aug; 149(2):321-329. PMID: 25980753.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  49. Hur C, Choi SE, Kong CY, Wang GQ, Xu H, Polydorides AD, Xue LY, Perzan KE, Tramontano AC, Richards-Kortum RR, Anandasabapathy S. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis. World J Gastroenterol. 2015 May 14; 21(18):5513-23. PMID: 25987774; PMCID: PMC4427673.
    Citations: 2     Fields:    Translation:Humans
  50. Hazelton WD, Curtius K, Inadomi JM, Vaughan TL, Meza R, Rubenstein JH, Hur C, Luebeck EG. The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1012-23. PMID: 25931440; PMCID: PMC4491004.
    Citations: 9     Fields:    Translation:Humans
  51. Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016 Apr; 65(4):563-74. PMID: 25779597; PMCID: PMC4573370.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  52. Pandharipande PV, Heberle C, Dowling EC, Kong CY, Tramontano A, Perzan KE, Brugge W, Hur C. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology. 2015 Apr; 275(1):177-87. PMID: 25393849; PMCID: PMC4372492.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  53. Swan JS, Kong CY, Hur C, Halpern EF, Itauma O, Williams O, Motazedi T, Lee JM. Comparing morbidities of testing with a new index: screening colonoscopy versus core-needle breast biopsy. J Am Coll Radiol. 2015 Mar; 12(3):295-301. PMID: 25441485.
    Citations:    Fields:    Translation:Humans
  54. Yachimski P, Hur C. Evidence-based endoscopic management of Barrett's esophagus. Gastroenterol Rep (Oxf). 2015 Feb; 3(1):54-62. PMID: 25237038; PMCID: PMC4324864.
    Citations: 2     
  55. Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):665-72.e1-4. PMID: 25218668.
    Citations: 9     Fields:    Translation:Humans
  56. Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle CR, Miller MC, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):997-1006. PMID: 24692500.
    Citations: 16     Fields:    Translation:Humans
  57. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90. PMID: 24681073; PMCID: PMC4227952.
    Citations: 1     Fields:    Translation:Humans
  58. Yasuda K, Choi SE, Nishioka NS, Rattner DW, Puricelli WP, Tramontano AC, Kitano S, Hur C. Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci. 2014 Jul; 59(7):1560-6. PMID: 24395382; PMCID: PMC4071117.
    Citations: 7     Fields:    Translation:Humans
  59. Choi SE, Perzan KE, Tramontano AC, Kong CY, Hur C. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila). 2014 Mar; 7(3):341-50. PMID: 24380852; PMCID: PMC3951678.
    Citations: 5     Fields:    Translation:Humans
  60. Swan JS, Hur C, Lee P, Motazedi T, Donelan K. Responsiveness of the testing morbidities index in colonoscopy. Value Health. 2013 Sep-Oct; 16(6):1046-53. PMID: 24041354.
    Citations:    Fields:    Translation:Humans
  61. Shaheen NJ, Hur C. Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus. Gastroenterology. 2013 Aug; 145(2):273-6. PMID: 23806540.
    Citations: 6     Fields:    Translation:Humans
  62. Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati M, Stout N, Ward Z, Goldie SJ. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med. 2013; 10(5):e1001451. PMID: 23700390; PMCID: PMC3660292.
    Citations: 13     Fields:    Translation:HumansCells
  63. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TR. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013 May; 144(5):1024-30. PMID: 23333348.
    Citations: 45     Fields:    Translation:HumansCells
  64. Ananthakrishnan AN, Korzenik JR, Hur C. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis. 2013 Jan; 19(1):37-44. PMID: 22416019.
    Citations: 11     Fields:    Translation:Humans
  65. Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013 Mar 15; 119(6):1149-58. PMID: 23303625; PMCID: PMC3744155.
    Citations: 95     Fields:    Translation:Humans
  66. Ladabaum U, Brill JV, Sonnenberg A, Shaheen NJ, Inadomi J, Wilcox CM, Park WG, Hur C, Pasricha PJ. How to value technological innovation: a proposal for determining relative clinical value. Gastroenterology. 2013 Jan; 144(1):5-8. PMID: 23153872.
    Citations:    Fields:    Translation:HumansPHPublic Health
  67. Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med. 2012 Nov 06; 157(9):611-20. PMID: 23128861; PMCID: PMC3515652.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  68. Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1. PMID: 22796132.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  69. Choi SE, Hur C. Screening and surveillance for Barrett's esophagus: current issues and future directions. Curr Opin Gastroenterol. 2012 Jul; 28(4):377-81. PMID: 22508325; PMCID: PMC3413257.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  70. Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology. 2012 Sep; 143(3):567-575. PMID: 22626608.
    Citations: 33     Fields:    Translation:Humans
  71. Omer ZB, Ananthakrishnan AN, Nattinger KJ, Cole EB, Lin JJ, Kong CY, Hur C. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):722-7. PMID: 22426086; PMCID: PMC3435144.
    Citations: 26     Fields:    Translation:Humans
  72. Kong CY, Nattinger KJ, Hayeck TJ, Omer ZB, Wang YC, Spechler SJ, McMahon PM, Gazelle GS, Hur C. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev. 2011 Nov; 20(11):2450-6. PMID: 21930957; PMCID: PMC3382986.
    Citations: 15     Fields:    Translation:Humans
  73. Ananthakrishnan AN, Hur C, Korzenik JR. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci. 2012 Feb; 57(2):472-80. PMID: 21909990.
    Citations: 7     Fields:    Translation:Humans
  74. Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol. 2011 Nov; 106(11):2009-17. PMID: 21788991.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  75. Ho W, Broughton DE, Donelan K, Gazelle GS, Hur C. Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population. AJR Am J Roentgenol. 2010 Aug; 195(2):393-7. PMID: 20651195; PMCID: PMC3717967.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  76. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer. 2010 Jun 15; 116(12):2941-53. PMID: 20564399; PMCID: PMC2946062.
    Citations: 19     Fields:    Translation:Humans
  77. Yeh JM, Ho W, Hur C. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc. 2010 Jul; 72(1):33-43. PMID: 20430384; PMCID: PMC2902548.
    Citations: 8     Fields:    Translation:HumansCells
  78. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010 Aug; 23(6):451-7. PMID: 20353441; PMCID: PMC2896446.
    Citations: 35     Fields:    Translation:Humans
  79. Hur C, Hayeck TJ, Yeh JM, Richards EM, Richards EB, Spechler SJ, Gazelle GS, Kong CY. Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One. 2010 Mar 01; 5(3):e9483. PMID: 20208996; PMCID: PMC2830429.
    Citations: 6     Fields:    Translation:Humans
  80. Huang ES, Turner BG, Fernandez-Del-Castillo C, Brugge WR, Hur C. Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):285-94. PMID: 19845568; PMCID: PMC2807915.
    Citations: 9     Fields:    Translation:Humans
  81. Huang ES, Gazelle GS, Hur C. Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci. 2010 Mar; 55(3):852-60. PMID: 19834805; PMCID: PMC2875154.
    Citations: 11     Fields:    Translation:Humans
  82. Yachimski P, Lee RA, Tramontano A, Nishioka NS, Hur C. Secular trends in patients diagnosed with Barrett's esophagus. Dig Dis Sci. 2010 Apr; 55(4):960-6. PMID: 19798573; PMCID: PMC3739456.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  83. Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS. Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2677-84. PMID: 19789369; PMCID: PMC2759853.
    Citations:    Fields:    Translation:Humans
  84. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14. PMID: 19057995; PMCID: PMC3737565.
    Citations:    Fields:    Translation:Humans
  85. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19. PMID: 18941062.
    Citations: 3     Fields:    Translation:Humans
  86. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42. PMID: 18775019; PMCID: PMC3736801.
    Citations: 5     Fields:    Translation:Humans
  87. Yachimski P, Hur C. Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis. Dig Dis Sci. 2009 Apr; 54(4):701-11. PMID: 18661236; PMCID: PMC3108178.
    Citations: 7     Fields:    Translation:Humans
  88. Yachimski P, Nishioka NS, Richards E, Hur C. Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol. 2008 Nov; 6(11):1206-11. PMID: 18619919; PMCID: PMC3113490.
    Citations: 7     Fields:    Translation:Humans
  89. Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology. 2008 Jul; 248(1):169-78. PMID: 18458248.
    Citations: 14     Fields:    
  90. Yeh JM, Kuntz KM, Ezzati M, Hur C, Kong CY, Goldie SJ. Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1179-87. PMID: 18483340.
    Citations: 13     Fields:    Translation:HumansCells
  91. Hur C, Yachimski P. How useful is histologic confirmation of intestinal metaplasia in patients with long-segment Barrett's esophagus? Nat Clin Pract Gastroenterol Hepatol. 2008 Mar; 5(3):140-1. PMID: 18212774; PMCID: PMC3085891.
    Citations:    Fields:    
  92. Kaplan GG, Hur C, Korzenik J, Sands BE. Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1509-20. PMID: 17931345.
    Citations: 16     Fields:    Translation:Humans
  93. Choi MY, Lauwers GY, Hur C, Willett CG, Chung DC. Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1584. PMID: 17674996.
    Citations: 7     Fields:    Translation:Humans
  94. Hur C. The Cost-Effectiveness of Virtual Colonoscopy and the Importance of Small Polyps. AGA Perspectives. 2007; 3(4):8-14.
  95. Hur C, Chung DC, Schoen RE, Gazelle GS. The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):237-44. PMID: 17296532.
    Citations: 10     Fields:    Translation:Humans
  96. Hur C. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow? Clin Gastroenterol Hepatol. 2007 Mar; 5(3):307-9. PMID: 17257904.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  97. Schoen RE, Hur C. What is the clinical importance of small polyps with regard to colorectal cancer screening? Nat Clin Pract Gastroenterol Hepatol. 2006 Sep; 3(9):488-9. PMID: 16951664.
    Citations: 4     Fields:    
  98. Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes. 2006 Aug 02; 4:45. PMID: 16884539; PMCID: PMC1559597.
    Citations: 3     Fields:    Translation:Humans
  99. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):1017-24; quiz 976. PMID: 16843733.
    Citations: 24     Fields:    Translation:Humans
  100. Hur C, Chan AT, Tramontano AC, Gazelle GS. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs. Ann Pharmacother. 2006 Jun; 40(6):1052-63. PMID: 16720709.
    Citations: 8     Fields:    Translation:Humans
  101. Pandharipande PV, Harisinghani MG, Specht MC, Hur C, Lee J, Gazelle GS . Staging MR Lymphangiography of the Axilla for Operable Breast Cancer: A Cost-Effectiveness Analysis. Oral Presentation at the Annual Meeting of the Radiological Society of North America, Chicago, IL Dec 2005. 2005.
  102. Hur C, Gazelle GS, Hsu EH, Halpern EF, Podolsky DK. The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1124-7. PMID: 16271344.
    Citations:    Fields:    Translation:Humans
  103. Jo WS, Bandipalliam P, Shannon KM, Niendorf KB, Chan-Smutko G, Hur C, Syngal S, Chung DC. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):1022-8. PMID: 16234049.
    Citations: 11     Fields:    Translation:Humans
  104. Hur C, Nishioka NS, Gazelle GS. Two models better than one. Gut. 2005 Aug; 54(8):1204; author reply 1204. PMID: 16009696; PMCID: PMC1774877.
    Citations:    Fields:    Translation:Humans
  105. Hur C, Wittenberg E, Nishioka NS, Gazelle GS. Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci. 2005 Jan; 50(1):116-25. PMID: 15712648.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  106. Hur C, Simon LS, Gazelle GS. Analysis of aspirin-associated risks in healthy individuals. Ann Pharmacother. 2005 Jan; 39(1):51-7. PMID: 15590881.
    Citations:    Fields:    Translation:Humans
  107. Genen L, Hur C, Chung R, Gazelle GS . Cost-Effectiveness of Radio-Frequency Ablation for the Treatment of Primary Hepatocellular Carcinoma in Transplant Eligible Patients - A State-Transition Monte Carlo Decision Analysis. Oral Presentation at the Annual Meeting of the Radiological Society of North America, Chicago, IL, Dec 2004. 2004.
  108. Hur C, Gazelle GS, Zalis ME, Podolsky DK. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology. 2004 Nov; 127(5):1312-21. PMID: 15521000.
    Citations: 8     Fields:    Translation:Humans
  109. Hur C, Simon LS, Gazelle GS. The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals. Cancer. 2004 Jul 01; 101(1):189-97. PMID: 15222006.
    Citations: 4     Fields:    Translation:Humans
  110. Hur C, Chung DC, Hsu EH, Evans JA, Gazelle GS. The Optimal Management for Duodenal Polyposis in Familial Adenomatous Polyposis. 2004; 125(4).
  111. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst. 2004 Feb 18; 96(4):316-25. PMID: 14970280.
    Citations: 20     Fields:    Translation:Humans
  112. Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci. 2003 Jul; 48(7):1273-83. PMID: 12870783.
    Citations: 13     Fields:    Translation:Humans
  113. Hur C, Gazelle GS. Screening First Degree Relatives of Patients with Celiac Disease. Gastroenterology. 2003; 124(4 supp):M2118.
  114. Hur C, Lembo A. Gaseousness and Indigestion. Conn's Current Therapy, Rakel RE, Bope ET. 2002.
  115. Zaman SZ, Hur C, Jones M, Krueger RF, Chavez N, Talley NJ, Lembo A. Concordance of Reflux Among Monozygotic and Dizygotic Twins. Gastroenterology. 2001; 120(5 supp):A2136.
  116. Hur C, Michetti P, Kelly C. Hp Eradication rates and symptoms in patients with proven peptic ulcer. American Journal of Gastroenterology. 2000; 95(9):2454.
  117. Jeong HJ, Lee MH, Ro KW, Hur CW, Kim JW. Determination of Panthenol, Cholecalciferol and Tocopherol in Cosmetic Products by Gas Chromatography-Mass Spectrometry in SIM Mode. Int J Cosmet Sci. 1999 Feb; 21(1):41-50. PMID: 18505529.
    Citations:    Fields:    
  118. Suerbaum S, Hur C, Josehans C, Michetti P. Pathogenesis and virulence factors of Helicobacter pylori. Current Opinion in Gastroenterology. 1999; 15(s1):11-16.
  119. Hur C, Appel L, Coresh J. The impact of Angiotensin Converting Enzyme Inhibitor Therapy on renal function in Diabetics: Results of a meta-analysis. American Journal of Hypertension. 1995; 8(4 Part II):40A.
  120. Brown NA, Kovacs A, Lui CR, Hur C, Zaia JA, Mosley JW. Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet. 1988 Nov 12; 2(8620):1146. PMID: 2903363.
    Citations: 4     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hur's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (292)
Explore
_
Co-Authors (64)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.